Sun Pharma
-
September 13, 2021, Monday
Sun Pharma stock expected to keep market lead as firm recovers in US
Stock trading at the highest discount to ten-year valuation averages, as brokerages favour its US specialty portfolio.
-
September 03, 2021, Friday
Vivek Chaand Sehgal resigns as director from Sun Pharmaceutical board
Drug firm Sun Pharmaceutical Industries on Friday said Vivek Chaand Sehgal has resigned as an independent director of the company ...
-
August 31, 2021, Tuesday
Sun Pharma gets exclusive right to commercialise Winlevi acne cream in US
Sun Pharma and specialty pharma firm Cassiopea SpA announced consummation of their exclusive licence and supply agreements for ...
-
July 31, 2021, Saturday
Top headlines: Sun Pharma's strong Q1 show, India-China military talks
Business Standard brings to you the top headlines on Saturday
-
July 30, 2021, Friday
Q1 results: Sun Pharma in the black, posts Rs 1,444-crore profit
Revenue from operations in the first quarter rose 29 per cent year-on-year and 14 per cent on a sequential basis to Rs 9,669
-
July 30, 2021, Friday
Sun Pharma: Strong Q1 show, settlement of antitrust case pleases investors
Lack of pricing pressure, especially in the US, and debt reduction are other positives
-
July 30, 2021, Friday
Top headlines: Sun Pharma posts profit in Q1; Bandhan Bank Q1 net falls 32%
Business Standard brings you the top headlines on Friday
-
July 30, 2021, Friday
Sun Pharma rallies 9%, hits over 4-year high on strong June quarter results
The management said Sun Pharma witnessed a strong Q1, driven by a combination of robust core business growth, low base and some ...
-
July 30, 2021, Friday
Sun Pharma posts consolidated net profit of Rs 1,444 crore in Q1
The company had posted a net loss of Rs 1,655.60 crore for the corresponding period of the previous fiscal
-
July 03, 2021, Saturday
NPPA allows 50% price hike for ibuprofen, ranitidine, carbamazepine
These are scheduled drugs (or ones that are under price control) and low priced
